ArticleJournal of clinical microbiology2006
Molecular epidemiology of Leishmania (Viannia) guyanensis in French Guiana.
Article in Journal of clinical microbiology, 2006. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 21 papers.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
21 citing papers in PubMed.
- Randomized controlled clinical trial to access efficacy and safety of miltefosine in the treatment of cutaneous leishmaniasis Caused by Leishmania (Viannia) guyanensis in Manaus, Brazil.The American journal of tropical medicine and hygiene · 2011Trial
- Travel history and occupation among diagnosed Cutaneous Leishmaniasis cases in Guyana: A multi-site retrospective case series, 2017-2021.PLoS neglected tropical diseases · 2026Article
- Resequencing and De Novo Assembly ofPathogens (Basel, Switzerland) · 2026Article
- Imported cases of cutaneous leishmaniasis in Cuba, 2017: role of human movement.Tropical diseases, travel medicine and vaccines · 2022Article
- Evaluation of cytochrome b sequence to identify Leishmania species and variants: the case of Panama.Memorias do Instituto Oswaldo Cruz · 2021Article
- Leishmania naiffi and lainsoni in French Guiana: Clinical features and phylogenetic variability.PLoS neglected tropical diseases · 2020Article
- Further insights into the eco-epidemiology of American cutaneous leishmaniasis in the Belem metropolitan region, Pará State, Brazil.Revista da Sociedade Brasileira de Medicina Tropical · 2020Article
- American cutaneous leishmaniasis in French Guiana: an epidemiological update and study of environmental risk factors.International journal of dermatology · 2019Article
- A review on the occurrence of companion vector-borne diseases in pet animals in Latin America.Parasites & vectors · 2019Review
- Article
- Salvia Species as Sources of Natural Products with Antiprotozoal Activity.International journal of molecular sciences · 2018Review
- Unraveling the genetic diversity and phylogeny of Leishmania RNA virus 1 strains of infected Leishmania isolates circulating in French Guiana.PLoS neglected tropical diseases · 2017Article
- Prevalence and Distribution of Leishmania RNA Virus 1 in Leishmania Parasites from French Guiana.The American journal of tropical medicine and hygiene · 2016Article
- Population structure and evidence for both clonality and recombination among Brazilian strains of the subgenus Leishmania (Viannia).PLoS neglected tropical diseases · 2013Article
- Identification of Leishmania spp. by molecular amplification and DNA sequencing analysis of a fragment of rRNA internal transcribed spacer 2.Journal of clinical microbiology · 2011Article
- Mucosal Leishmaniasis caused by Leishmania (Viannia) braziliensis and Leishmania (Viannia) guyanensis in the Brazilian Amazon.PLoS neglected tropical diseases · 2011Article
- First cases of cutaneous leishmaniasis caused by Leishmania (Viannia) naiffi infection in Surinam.The American journal of tropical medicine and hygiene · 2010Article
- Leishmaniasis, Suriname.Emerging infectious diseases · 2008Article
- Recurrent American cutaneous leishmaniasis.Emerging infectious diseases · 2007Article
- Leishmania isoenzyme polymorphisms in Ecuador: relationships with geographic distribution and clinical presentation.BMC infectious diseases · 2006Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
7 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Little information is available about the genetic variability of Leishmania populations and the possible correlations with ecoepidemiological features of leishmaniases. The present study was carried out in French Guiana, a country where cutaneous leishmaniases (CL) are endemic over the whole territory. The genetic polymorphism of a nuclear sequence encompassing the end of the ribosomal small subunit and the internal transcribed spacer 1 of 265 isolates from patients with CL was examined by restriction fragment length polymorphism analysis. Genotypes based on the fingerprinting phenetic integration were compared to epidemiological, clinical, and geographical data. In agreement with previous reports, five different Leishmania species were identified, but Leishmania (Viannia) guyanensis represented 95.8% of the samples. Two distinct L. (V.) guyanensis populations were found to originate in two ecologically characterized regions. Higher lesional parasite densities and the need for additional treatments were significantly linked to genotype group I. Parasites of genotype group II were more likely to cause chronic and disseminated cutaneous forms in patients. L. (V.) guyanensis was previously said not to be very polymorphic; however, the present analysis resulted in a significant degree of discrimination among L. (V.) guyanensis isolates from diverse ecological areas and with different clinical implications.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.